Skip to content

TransMedics

US · TMDX #2536 by market cap Listed 2019
85.25 -8.77 -9.33%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 0 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Oppenheimer moved from Buy to Hold on 2026-05-06.

Analyst consensus 9 analysts

Buy
Avg price target 104.75 +22.9%
Price target rangecurrent 85.25
Low70.00
Avg104.75
High120.00
Buy 78% Hold 22% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-09 Barclays -- Buy 120.00
2026-11-06 CCORF -- Buy 120.00
2026-11-06 Piper Sandler -- Buy 100.00
2026-11-06 Baird -- Buy 117.00
2026-11-06 Stifel -- Hold 70.00
2026-11-06 J.P. Morgan -- Hold 85.00
2026-11-03 Piper Sandler -- Buy 100.00
2026-11-02 TD Cowen -- Buy 120.00
2026-10-13 CCORF -- Buy 94.00
2026-10-06 Barclays -- Buy 120.00
2026-10-05 Piper Sandler -- Buy 100.00
2026-10-02 TD Cowen -- Buy 120.00
2026-10-02 William Blair -- Buy --
2026-09-22 Needham -- Buy 106.00
2026-09-11 CCORF -- Buy 95.00
2026-09-11 Piper Sandler -- Buy 100.00
2026-09-11 Needham -- Buy 106.00
2026-09-10 William Blair -- Buy --
2026-09-08 TD Cowen -- Buy 120.00
2026-09-02 TD Cowen -- Buy 120.00
2026-09-02 Piper Sandler -- Buy 90.00
2026-08-24 Oppenheimer -- Hold --
2026-08-12 CCORF -- Buy 95.00
2026-08-11 CCORF -- Buy 95.00
2026-08-05 TD Cowen -- Buy 120.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-05-06 Oppenheimer Buy → Hold 175.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 After close ±17.98% +27.92% (beat)
2026/Q2 2026-08-04 After close ±15.60% -5.28% (in line)
2026/Q1 2026-05-05 After close ±12.87% -23.19% (beat)
2025/Q4 2026-02-24 After close ±15.97% -4.30% (in line)
2025/Q3 2025-10-29 After close ±17.52% +1.09% (in line)
2025/Q2 2025-07-30 After close ±19.01% +10.46% (in line)
2025/Q1 2025-05-08 After close ±19.30% +19.64% (beat)
2024/Q4 2025-02-27 After close ±27.26% +5.82% (in line)
2024/Q3 2024-10-28 After close ±24.84% -29.90% (beat)
2024/Q1 2024-04-30 After close ±18.67% +24.93% (beat)
2023/Q4 2024-02-26 After close ±27.53% +14.11% (in line)
2023/Q3 2023-11-06 After close ±20.79% +51.18% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

TransMedics discussion 0 comments

Add a comment